Sigma Planning Corp Buys 308 Shares of Humana Inc (NYSE:HUM)

Sigma Planning Corp increased its stake in Humana Inc (NYSE:HUM) by 23.6% during the second quarter, HoldingsChannel reports. The firm owned 1,613 shares of the insurance provider’s stock after acquiring an additional 308 shares during the period. Sigma Planning Corp’s holdings in Humana were worth $428,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of HUM. Diamond Hill Capital Management Inc. bought a new stake in shares of Humana in the 2nd quarter worth approximately $86,802,000. Ceredex Value Advisors LLC raised its holdings in shares of Humana by 31.8% in the 1st quarter. Ceredex Value Advisors LLC now owns 957,094 shares of the insurance provider’s stock worth $255,111,000 after purchasing an additional 230,671 shares during the period. BlackRock Inc. raised its holdings in Humana by 1.6% during the 1st quarter. BlackRock Inc. now owns 12,190,049 shares of the insurance provider’s stock valued at $3,242,553,000 after acquiring an additional 186,997 shares during the period. Geode Capital Management LLC raised its holdings in Humana by 8.3% during the 4th quarter. Geode Capital Management LLC now owns 1,773,576 shares of the insurance provider’s stock valued at $507,198,000 after acquiring an additional 135,776 shares during the period. Finally, Janus Henderson Group PLC raised its holdings in Humana by 3.5% during the 1st quarter. Janus Henderson Group PLC now owns 3,596,204 shares of the insurance provider’s stock valued at $956,594,000 after acquiring an additional 120,905 shares during the period. 89.88% of the stock is currently owned by institutional investors.

A number of brokerages have issued reports on HUM. Cantor Fitzgerald raised shares of Humana from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $300.00 to $345.00 in a report on Monday, August 12th. JPMorgan Chase & Co. boosted their target price on shares of Humana from $288.00 to $322.00 and gave the company an “overweight” rating in a report on Thursday, August 1st. Piper Jaffray Companies boosted their target price on shares of Humana from $315.00 to $341.00 and gave the company an “overweight” rating in a report on Thursday, August 1st. Citigroup lowered their target price on shares of Humana from $362.00 to $302.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Finally, ValuEngine raised shares of Humana from a “sell” rating to a “hold” rating in a report on Friday, July 12th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $342.26.

Shares of Humana stock traded up $1.91 during trading on Wednesday, hitting $296.33. The stock had a trading volume of 2,396 shares, compared to its average volume of 1,162,440. The firm has a market cap of $40.12 billion, a price-to-earnings ratio of 20.42, a P/E/G ratio of 1.28 and a beta of 0.85. Humana Inc has a 12 month low of $225.65 and a 12 month high of $355.88. The business’s 50-day moving average is $284.64 and its 200 day moving average is $271.89. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.37.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.81. The firm had revenue of $16.25 billion for the quarter, compared to analysts’ expectations of $15.88 billion. Humana had a net margin of 4.13% and a return on equity of 22.47%. The business’s quarterly revenue was up 13.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.96 earnings per share. As a group, equities analysts expect that Humana Inc will post 17.63 EPS for the current year.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Story: Google Finance Portfolio Tips and Tricks

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.